Phase II Study of Four Concentrations of Intraperitoneal NanoPac® Plus Six Cycles of IV Carboplatin and Paclitaxel in Patients With Platinum-Sensitive Recurrent Stage III Epithelial Ovarian Cancer Undergoing Second Cytoreductive Surgery
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Nanology
- 31 Aug 2018 Biomarkers information updated
- 09 Oct 2017 According to a Nanology media release, the first patient has been enrolled in this trial.
- 12 Apr 2017 Status changed from not yet recruiting to recruiting.